Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.54 |
| ▸ | RAB9A | P51151 | 5/20 | 0.54 |
| ▸ | CASP3 | P42574 | 2/20 | 0.54 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.45 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.45 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.45 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | CES1 | P23141 | 2/20 | 0.42 |
| ▸ | PLAU | P00749 | 1/20 | 0.42 |
| ▸ | DRD4 | P21917 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | F10 | P00742 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1175407 | 1.00 | NPC1 (0.54) | NPC1RAB9ACASP3SENP7KMT2A | |
| SCHEMBL2002642 | 0.89 | CES2 (0.54) | NPC1RAB9AKMT2AKDM4ECES2 | |
| SCHEMBL12311740 | 0.89 | CES2 (0.54) | NPC1RAB9AKMT2AKDM4ECES2 | |
| SCHEMBL1176115 | 0.88 | NPC1 (0.52) | NPC1RAB9ACASP3SENP7KMT2A | |
| SCHEMBL24704161 | 0.88 | NPC1 (0.47) | NPC1RAB9ACASP3SENP7KMT2A | |
| SCHEMBL12433231 | 0.82 | NPC1 (0.42) | NPC1RAB9ACASP3SENP7KMT2A | |
| SCHEMBL29115778 | 0.81 | SYK (0.41) | NPC1RAB9ACASP3SENP7KMT2A | |
| SCHEMBL548361 | 0.80 | ALDH1A1 (0.52) | NPC1RAB9AKMT2ACES2CES1 | |
| SCHEMBL10062049 | 0.78 | HPGD (0.48) | NPC1RAB9ACASP3SENP7KMT2A | |
| SCHEMBL15805572 | 0.77 | CES2 (0.57) | NPC1RAB9AKDM4ECES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7981402-B2 | Alkyl benzene sulfonyl urea photostabilizers and UV-absorbers | HALLSTAR INNOVATIONS CORP. (US) | 2011-07-19 | — | — | US | disclosed |
| US-7981402-B2 | Alkyl benzene sulfonyl urea photostabilizers and UV-absorbers | HALLSTAR INNOVATIONS CORP. (US) | 2011-07-19 | — | — | US | disclosed |
| US-20110033396-A1 | NOVEL PHOTOSTABILIZERS, UV ABSORBERS, AND METHODS OF PHOTOSTABILIZING COMPOSITIONS | HALLSTAR ONNOVATIONS CORP. (US) | 2011-02-10 | — | — | US | disclosed |
| US-20110033396-A1 | NOVEL PHOTOSTABILIZERS, UV ABSORBERS, AND METHODS OF PHOTOSTABILIZING COMPOSITIONS | HALLSTAR ONNOVATIONS CORP. (US) | 2011-02-10 | — | — | US | disclosed |
| US-7799317-B2 | Photostabilizers, UV absorbers, and methods of photostabilizing compositions | HALLSTAR INNOVATIONS CORP. (US) | 2010-09-21 | — | — | US | disclosed |
| US-7799317-B2 | Photostabilizers, UV absorbers, and methods of photostabilizing compositions | HALLSTAR INNOVATIONS CORP. (US) | 2010-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110033396-A1 | NOVEL PHOTOSTABILIZERS, UV ABSORBERS, AND METHODS OF PHOTOSTABILIZING COMPOSITIONS | ERCC1, ERCC4, TTPA | NPC1 2554/4885RAB9A 3457/4885CASP3 2540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.